MARKET

DXR

DXR

DAXOR CORP
NASDAQ
9.79
+0.04
+0.41%
Closed 16:00 04/22 EDT
OPEN
9.79
PREV CLOSE
9.75
HIGH
9.79
LOW
9.79
VOLUME
477
TURNOVER
0
52 WEEK HIGH
13.13
52 WEEK LOW
7.11
MARKET CAP
46.36M
P/E (TTM)
167.64
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at DXR last week (0415-0419)?
Weekly Report · 13h ago
Weekly Report: what happened at DXR last week (0408-0412)?
Weekly Report · 04/15 10:01
Daxor’s Promising Growth and Innovation Outlook Merit a Buy Rating
TipRanks · 04/15 09:17
DAXOR CORP <DXR.O>: ASCENDIANT CAPITAL MARKETS RAISES TARGET PRICE TO $24.5 FROM $24
Reuters · 04/15 03:08
Weekly Report: what happened at DXR last week (0401-0405)?
Weekly Report · 04/08 10:04
Weekly Report: what happened at DXR last week (0325-0329)?
Weekly Report · 04/01 10:03
Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)
Vigil Neuroscience Inc has an analyst consensus of Strong Buy, with a price target of $19.33. Daxor has a 548.7% upside from current levels. 2 analysts have reiterated a Buy rating on Vigil Neuroscience Inc. The company's shares closed at $2.79 yesterday.
TipRanks · 03/27 11:30
Daxor acquires Volumex and Megatope from existing supplier
Healthcare Daxor acquires Volumex and Megatope from existing supplier from privately-held Iso-Tex Diagnostics. The company also acquired the exclusive rights to Glofil, a drug that measures glomerular filtration rate (GFR) The company projects the acquisitions to be cash flow positive.
Seeking Alpha · 03/25 12:41
More
About DXR
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. It is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. It has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

Webull offers Daxor Corp stock information, including NASDAQ: DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.